logo

Silver Nanoparticles in Therapeutics: Antimicrobial Gel

PDF Publication Title:

Silver Nanoparticles in Therapeutics: Antimicrobial Gel ( silver-nanoparticles-therapeutics-antimicrobial-gel )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 011

SilVer Nanoparticle Based Formulation for Topical Use articles Figure 11. Confocal micrographs of acridine orange/ethidium bromide stained Hep G2 cells. (A) Unexposed (control) cells have a normal green nucleus indicating live cells. (B) Cells exposed to ∼(1/2)IC50 SNP (125 μg/mL) for 24 h display bright green nucleus with condensed or fragmented chromatin suggesting apoptosis. (C) Cells exposed to ∼2 × IC50 SNP (500 μg/mL) for 24 h have a structurally normal orange nucleus indicative of necrosis. Scale bar indicates 100 μm. Table 5. Quantification of AO/EB Stained Hep G2 Cells (%)a after Exposure to SNP (∼(1/2)IC50 SNP and 2 × IC50) for 24 h A study by Panacek et al.19 described synthesis of silver nanoparticles of varying sizes (but narrow size distributions) using four different saccharides. The antimicrobial property of these nanoparticles against many Gram-positive and Gram- negative bacteria including multidrug-resistant strains was found to be size dependent. Nanoparticles with size >25 nm exhibited MIC of 6.75-54 μg/mL whereas 25 nm size particles showed MIC in the range of 1.69-13.5 μg/mL. The MIC results obtained with 25 nm particles are comparable to those obtained by us in the present study, where SNP suspension containing 7-20 nm particles were used. This is an important result, particularly when antibiotic resistance among bacterial species is increasing at an alarming rate and very few alternative options are available to address the issue. Park et al.20 showed that hybrid silver (Ag) nanoparticles (size 3-7 nm) loaded on SiO2 nanoparticles inhibited a range of standard fungi at concentration of 1 ppm. However, in our study, the obtained antifungal concentrations are 25-fold (∼25 μg/mL). An interesting observation on variation in antimicrobial activity of silver nanoparticles due to strain specificity has been discussed by Ruparelia et al.21 They showed that among the tested strains of Escherichia coli (four strains), Bacillus subtilis and Staphylococcus aureus (three strains), Escherichia coli strains showed maximum variation in the silver nanoparticle induced antimicrobial activity. Our results corroborate these findings as we find a lot of strain- dependent variation in antimicrobial response of SNP activ- ity. In another study the MIC and MBC of Acticoat with S. aureus, S. epidermidis, E. coli, K. aerogenes and P. aerugi- nosa was reported to be 5-12.5 μg/mL,22,23 which compares well with the results obtained with SNP. It was reported that (19) Panacek, A.; Kvitek, L.; Prucek, R.; Kolar, M.; Vecerova, R.; Pizurova, N.; Sharma, V. K.; Nevecna, T.; Zboril, R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J. Phys. Chem. B 2006, 110, 16248–16253. (20) Park, H.-J.; Kim, H. J.; Kim, S. H.; Oh, S.-D.; Choi, S.-H. Radiolytic synthesis of hybrid silver nanoparticles and their biobehavior. Key Eng. Mater. 2007, 342-343, 897–900. (21) Ruparelia, J. P.; Chatterjee, A. K.; Duttagupta, S. P.; Mukherji, S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomaterialia 2008, 4, 707–716. (22) Burrel, R. E.; McIntosh, C. L.; Morris, I. R. Process of activating antimicrobials materials. 1995, US Patent 5,455,886. type of cells live cells apoptotic cells necrotic cells SNP (125 μg/mL) SNP (500 μg/mL) control (unexposed) cells 96 ( 3 3 ( 2 1 ( 1 exposed to ∼(1/2)IC50 exposed to ∼2 × IC50 a The data are expressed as mean ( standard deviation (SD) of three independent experiments. Asterisk (*) denotes a statistically significant difference compared to control (p < 0.05). nanoparticles. Cho et al.16 reported that poly-(N-vinyl-2- pyrrolidone) (PVP) stabilized silver nanoparticles showed MIC of 5 μg/mL against S. aureus and 10 μg/mL against E. coli. S. aureus and E. coli were completely inhibited at 50 and 100 μg/mL silver. Raffi et al.17 reported that silver nanoparticles (mean size 16 nm) synthesized by inert gas condensation (IGC) method were effective bactericide against Escherichia coli, at concentration 60 μg/mL and higher. In another study, Shahverdi et al.18 synthesized silver nano- particles using culture supernatants of Klebsiella pneumoniae for reduction of aqueous Ag+ ions. The antimicrobial activity of silver nanoparticles against Staphylococcus aureus and Escherichia coli was assessed by diffusion assay. It was also observed that activities of various antibiotics (penicillin G, amoxicillin, erythromycin, clindamycin, and vancomycin) were increased in the presence of silver nanoparticles. In the present study, MIC results obtained with SNP are comparable to those reported by Cho et al.16 for PVP stabilized silver nanoparticles. (16) Cho, K. H.; Park, J. E.; Osaka, T.; Park, S. G. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim. Acta 2005, 51, 956–60. (17) Raffi, M.; Hussain, F.; Bhatti, T. M.; Akhter, J. I.; Hameed, A.; Hasan, M. M. Antibacterial Characterization of Silver Nanopar- ticles against E. coli ATCC-15224. J. Mater. Sci. Technol. 2008, 24, 192–196. (18) Shahverdi, A. R.; Fakhimi, A.; Shahverdi, H. R.; Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed.: Nanotechnol., Biol., Med. 2007, 3, 168–171. 67 ( 5* 28 ( 5* 5 ( 1* 53 ( 6* 11 ( 3* 36 ( 3* VOL. 6, NO. 5 MOLECULAR PHARMACEUTICS 1397

PDF Image | Silver Nanoparticles in Therapeutics: Antimicrobial Gel

silver-nanoparticles-therapeutics-antimicrobial-gel-011

PDF Search Title:

Silver Nanoparticles in Therapeutics: Antimicrobial Gel

Original File Name Searched:

SilverNanoparticlesinTherapeutics-TopicalUse.pdf

DIY PDF Search: Google It | Yahoo | Bing

Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info

Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info

All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info

CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info

Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info

Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info

Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.

Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.

CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com | RSS | AMP